Skip to main content
. 2017 May 2;2(2):e000132. doi: 10.1136/esmoopen-2016-000132

Table 2.

DLTs registered during the first 2 weeks of combined treatment of metformin and erlotinib

Dose level Dose of metformin (mg) Dose of erlotinib (mg) Patients (n) DLT (patients, n)
1 2000 150 3 Grade 3 vomiting (1), Grade 3 diarrhoea (1)
2 1500 150 9 None

DLT, dose-limiting toxicity.